Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas

Cancers
Koichi NakamuraAkihiro Sudo

Abstract

Interleukin-6 (IL-6) affects the key parameters of oncogenesis, which increases the cell resistance to apoptosis, the proliferation of cancer cells, angiogenesis, invasion, malignancy, and the ability of tumor cells to respond to anticancer therapy. This study aimed to elucidate the association between IL-6 and IL-6 receptor (IL-6R) expression in tissues and clinical outcomes in patients with soft tissue sarcomas (STSs) because, to our knowledge, this has not been done before. We enrolled 86 patients with histologically-proven localized STSs who underwent surgical resection. The cohort included 48 men and 38 women, with a mean age of 65.6 years. The mean follow-up duration was 40.5 months. The expression of IL-6 and IL-6R was immunohistochemically determined. We analyzed prognostic factors for overall survival (OS) and metastasis-free survival (MFS). High IL-6 expression was observed in 23.3% (20/86), high IL-6R expression in 44.2% (38/86), and high expression of both in 16.3% (14/86) of patients. Multivariate analysis showed that a high expression of both IL-6 and IL-6R was a prognostic factor for OS and MFS. We found that this high expression indicated that the patient had a poor prognosis for OS and MFS.

References

Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L GuillouJ Costa
Jul 3, 1997·International Journal of Cancer. Journal International Du Cancer·M OkamotoR Oyasu
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Piotr RutkowskiJan Steffen
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Sep 2, 2011·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Hidefumi KitaTomoyuki Goya
Jul 6, 2014·Cytokine·Janina WolfChristoph Garbers
Jun 5, 2016·Biochemistry. Biokhimii︠a︡·O S DmitrievaS I Grivennikov
Jul 28, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Vivian LabovskyNorma Alejandra Chasseing
Mar 30, 2017·World Journal of Gastroenterology : WJG·Jun ZengShan-Shan Guo
Apr 18, 2019·Immunity·Sujin KangTadamitsu Kishimoto
Jul 23, 2019·Cancer Investigation·C SimondurairajGanesh Venkatraman

❮ Previous
Next ❯

Citations

Nov 24, 2020·Journal of Cardiac Surgery·Rodolphe DurieuxJean-Olivier Defraigne

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
ELISA

Software Mentioned

EZR
R
R Commander

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.